282 related articles for article (PubMed ID: 35533735)
1. The Underrecognized Conditions of Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders in Women.
Robbins K
Nurs Womens Health; 2022 Jun; 26(3):174-183. PubMed ID: 35533735
[TBL] [Abstract][Full Text] [Related]
2. Subjective health complaints and illness perception amongst adults with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-HypermobilityType - a cross-sectional study.
Hope L; Juul-Kristensen B; Løvaas H; Løvvik C; Maeland S
Disabil Rehabil; 2019 Feb; 41(3):333-340. PubMed ID: 29041819
[TBL] [Abstract][Full Text] [Related]
3. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
Estrella E; Frazier PA
Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
[TBL] [Abstract][Full Text] [Related]
4. Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review.
Peterson B; Coda A; Pacey V; Hawke F
J Foot Ankle Res; 2018; 11():59. PubMed ID: 30455744
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
Teran-Wodzinski P; Kumar A
Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
[TBL] [Abstract][Full Text] [Related]
6. Hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders in older women: A feasibility study.
Anderson LK; Lane KR
Musculoskeletal Care; 2023 Sep; 21(3):741-748. PubMed ID: 36864687
[TBL] [Abstract][Full Text] [Related]
7. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
Yew KS; Kamps-Schmitt KA; Borge R
Am Fam Physician; 2021 Apr; 103(8):481-492. PubMed ID: 33856167
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic Joint Hypermobility: The Hypermobile Type of Ehlers-Danlos Syndrome and the Hypermobility Spectrum Disorders.
Tinkle BT; Levy HP
Med Clin North Am; 2019 Nov; 103(6):1021-1033. PubMed ID: 31582002
[TBL] [Abstract][Full Text] [Related]
9. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
[TBL] [Abstract][Full Text] [Related]
10. Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome.
Forghani I
Balkan Med J; 2019 Jan; 36(1):12-16. PubMed ID: 30063214
[TBL] [Abstract][Full Text] [Related]
11. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
[TBL] [Abstract][Full Text] [Related]
12. Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.
Micale L; Fusco C; Castori M
Adv Exp Med Biol; 2021; 1348():207-233. PubMed ID: 34807421
[TBL] [Abstract][Full Text] [Related]
13. Understanding hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorders in the context of childbearing: An international qualitative study.
Pezaro DS; Pearce DG; Reinhold DE
Midwifery; 2020 Sep; 88():102749. PubMed ID: 32535291
[TBL] [Abstract][Full Text] [Related]
14. Predictors of pain and mobility disability in the hypermobile Ehlers-Danlos syndrome.
Kalisch L; Hamonet C; Bourdon C; Montalescot L; de Cazotte C; Baeza-Velasco C
Disabil Rehabil; 2020 Dec; 42(25):3679-3686. PubMed ID: 31060411
[No Abstract] [Full Text] [Related]
15. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
[TBL] [Abstract][Full Text] [Related]
16. Masterclass: Hypermobility and hypermobility related disorders.
Simmonds JV
Musculoskelet Sci Pract; 2022 Feb; 57():102465. PubMed ID: 34808594
[TBL] [Abstract][Full Text] [Related]
17. [[Joint hypermobility: when to evoke Ehlers-Danlos syndrome]?].
P Germain D
Rev Prat; 2016 Apr; 66(4):423-429. PubMed ID: 30512708
[TBL] [Abstract][Full Text] [Related]
18. Mast cell activation disease and immunoglobulin deficiency in patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorder.
Brock I; Prendergast W; Maitland A
Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):473-481. PubMed ID: 34747107
[TBL] [Abstract][Full Text] [Related]
19. Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.
Fernandez A; Jaquet M; Aubry-Rozier B; Suter M; Aybek S; Berna C
Brain Behav; 2024 Feb; 14(2):e3441. PubMed ID: 38409931
[TBL] [Abstract][Full Text] [Related]
20. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
Thwaites PA; Gibson PR; Burgell RE
J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
